OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 28, 2023

Primary Completion Date

June 15, 2029

Study Completion Date

June 15, 2029

Conditions
Non-small Cell Lung Cancer
Trial Locations (25)

Unknown

RECRUITING

Research Site, Alicante

RECRUITING

Research Site, Barcelona

NOT_YET_RECRUITING

Research Site, C Rdoba

RECRUITING

Research Site, Girona

RECRUITING

Research Site, Gran Canaria

RECRUITING

Research Site, Granada

RECRUITING

Research Site, Ja N

RECRUITING

Research Site, L Rida

RECRUITING

Research Site, La Coru A

RECRUITING

Research Site, León

NOT_YET_RECRUITING

Research Site, M Laga

RECRUITING

Research Site, Madrid

RECRUITING

Research Site, Murcia

RECRUITING

Research Site, Ourense

RECRUITING

Research Site, Palma

RECRUITING

Research Site, Sabadell

NOT_YET_RECRUITING

Research Site, Salamanca

RECRUITING

Research Site, Santa Cruz de Tenerife

RECRUITING

Research Site, Santander

RECRUITING

Research Site, Santiago de Compostela

RECRUITING

Research Site, Seville

RECRUITING

Research Site, Valencia

RECRUITING

Research Site, Valladolid

RECRUITING

Research Site, Vigo

RECRUITING

Research Site, Zaragoza

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY